Dechra

Northwich, United Kingdom Founded: 1997 • Age: 29 yrs Listed Acquired By EQT
Veterinary pharmaceuticals and related products are manufactured globally.

About Dechra

Dechra is a company based in Northwich (United Kingdom) founded in 1997, and was acquired by EQT in June 2023. Veterinary pharmaceuticals and related products are manufactured globally. The company has 1,945 employees. Dechra has completed 10 acquisitions, including AST Farma, AmPharmCo and Brovel. Its chief executive, as recorded, is Ian Page. Its website dechra.com draws about 42 thousand monthly visits. Dechra offers products and services including Veterinary Pharmaceuticals and Related Products. Its legal entity is Dechra Pharmaceuticals PLC.

Company details

Dechra was founded in 1997 and is headquartered in Northwich, United Kingdom. Veterinary pharmaceuticals and related products are developed, manufactured, marketed, and sold exclusively to veterinarians. Operations emphasize improvements in animal health and welfare, with educational resources provided to support veterinary professionals. Partnerships are maintained worldwide, though product distribution varies by region.

  • Headquarters Northwich, United Kingdom
  • Employees 1,945
  • Stage Acquired
  • Website category Pets and Animals · Pet Food and Supplies
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website dechra.com
  • Social LinkedIn X
  • Acquired by EQT (Jun 2023)
  • Legal Name Dechra Pharmaceuticals Plc
Key Metrics

Products & Services of Dechra

Dechra offers a comprehensive portfolio of products and services, including Veterinary Pharmaceuticals and Related Products.

Veterinary Pharmaceuticals
Animal Health Products

High-quality pharmaceuticals for animals are developed, manufactured, and marketed exclusively for veterinarians

Related Products
Veterinary Services

Related products for animal health are marketed and distributed to support veterinary professionals globally

Investors in Dechra

Dechra has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include EQT.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
EQT is recognized as a global investment organization focused on value creation.
1994eqtgroup.comStockholm, Sweden
Premium access

Investor details for Dechra

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Dechra

180 people are tracked at Dechra (71 in leadership, 1 in board & advisors, 108 in team); the tracked headcount is 1,945.

NameRoleGroup
Ian Page
CEOLeadership
William W.
Chief Digital & Information OfficerLeadership
Shannon Lancaster
Sr. Director Of Commercial AnalysisLeadership
Tammy Rice
Director, Marketing OperationLeadership
Ramon Bouwmans
Commercial Director Dechra InternationalLeadership
David Olver
Director, Anesthesia Product SalesLeadership
Giles Coley
Dechra Veterinary Products International Group DirectorLeadership
Jesper Nordengaard
Chief Executive OfficerLeadership
Katy Clough
Chief People OfficerLeadership
Clint Morris
Finance Director - EuropeLeadership
Melissa Carey
Finance Business PartnerLeadership
Jose Ostos
Chief Transformation OfficerLeadership
Catherine Knupp
Interim Chief Scientific Officer.Leadership
Laura Olsen
President, North AmericaLeadership
Juergen Horn
President, InvetxLeadership
Susan Egstrand
President Europe & International & Chief Commercial OfficerrLeadership
Maron Cornelissen
HR Business Partner EuropeLeadership
Garry Haswell
Site DirectorLeadership
Greg Underwood
Director Of Strategic AccountsLeadership
Marike Visser Dvm
Chief Development Officer, Invetx DivisionLeadership

160 more people are available in the full profile.

Premium access

Complete people profiles for Dechra

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Dechra

Dechra has strategically engaged in corporate development activities, having acquired 10 companies. Notable acquisitions include AST Farma, AmPharmCo and Brovel.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Provider of pharmaceutical products like protein-based therapeutics for pets
invetx.comBoston, United States2018Jul 2024$520M
Generic human and veterinary drugs are manufactured by Med-Pharmex.
medpharmex.comPomona, United States1983Aug 2022$260M
Medicinal products for companion and farm animals are developed.
piedmontanimalhealth.comGreensboro, United States2001Jul 2022$210M
Manufacturer of veterinary pharmaceutical products
ampharmco.comFort Worth, United States1999Aug 2019$29.98M
Animal healthcare products are manufactured for veterinary use.
venco.com.brLondrina, Brazil1986Oct 2018$49.42M
Domain names and related digital assets are managed and held.
caledonianholdings.comEast Kilbride, United Kingdom0Oct 2018$5.77M
Veterinary pharmaceuticals are manufactured and distributed by Le Vet. Pharma.
levetpharma.comOudewater, Netherlands2002Jan 2018β€’β€’β€’β€’
Manufacturing and supplying of veterinary products is conducted.
astfarma.nlOudewater, Netherlands1997Jan 2018β€’β€’β€’β€’
Provider of veterinary health products
rxvet.co.nzNew Zealand2010Dec 2017β€’β€’β€’β€’
Industrial automation and control solutions are provided for various sectors.
brovel.com.mxMexico0Jun 2016β€’β€’β€’β€’
Premium access

Complete acquisition details for Dechra

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Dechra

13 dated milestones of Dechra across 27 years, from founding to its latest funding, stage changes and deals.

  1. Founded Dechra is founded.
  2. IPO Lists on the stock exchange (IPO).
  3. Acquisition Acquires Brovel.
  4. Acquisition Acquires RxVet.
  5. Acquisition Acquires Le Vet. Pharma.
  6. Acquisition Acquires AST Farma.
  7. Acquisition Acquires Caledonianholdings.
  8. Acquisition Acquires Venco Animal Health.
  9. Acquisition Acquires AmPharmCo.
  10. Acquisition Acquires Piedmont Animal Health.
  11. Acquisition Acquires Med-Pharmex.
  12. Exit Acquired by EQT.
  13. Acquisition Acquires Invetx.

Web traffic of Dechra

The website of Dechra (dechra.com) receives about 42.4K visits a month and ranks #775,635 among all websites worldwide, #6,622 in Pet Food and Supplies.

  • Monthly visits
    42.4K

    ▲ 18.1% vs previous month

  • Unique visitors
    15.2K

    per month

  • Global rank
    #775,635

    among all websites

  • Category rank
    #6,622

    Pets and Animals · Pet Food and Supplies

Similar websites

Websites whose visitors overlap most with Dechra. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
dechra-us.com
dechra-us.com
100%
#528,114–
msd-animal-health.co.uk
msd-animal-health.co.uk
69%
#3,306,667–
elanco.com
64%
592.4K#115,154View details
norbrook.com
norbrook.com
62%
#812,631–
marketplace.dvm360.com
marketplace.dvm360.com
58%
–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 10 similar websites and full traffic analytics for Dechra

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 10 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Dechra

Premium access

Complete news archive for Dechra

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Dechra

Dechra was founded in 1997.

Dechra is headquartered in Northwich, United Kingdom.

Ian Page is the CEO of Dechra, as recorded in our data.

Dechra has 1,945 employees.

Dechra was founded in 1997 and is headquartered in Northwich, United Kingdom. Veterinary pharmaceuticals and related products are developed, manufactured, marketed, and sold exclusively to veterinarians. Operations emphasize improvements in animal health and welfare, with educational resources provided to support veterinary professionals. Partnerships are maintained worldwide, though product distribution varies by region.

Dechra offers Veterinary Pharmaceuticals and Related Products.

Dechra has made 10 acquisitions, including AST Farma, AmPharmCo, and Brovel.

Dechra has 1 investor. Key investors include EQT.

Dechra operates through Dechra Pharmaceuticals Plc.

Yes. Dechra was acquired by EQT in June 2023.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available